198 related articles for article (PubMed ID: 9808113)
1. The outcome of prescribing novel anticonvulsants in an outpatient setting: factors affecting response to medication.
Thijs RD; Kerr MP
Seizure; 1998 Oct; 7(5):379-83. PubMed ID: 9808113
[TBL] [Abstract][Full Text] [Related]
2. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Chadwick DW
BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
[TBL] [Abstract][Full Text] [Related]
3. Refractory epilepsy: treatment with new antiepileptic drugs.
Datta PK; Crawford PM
Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
[TBL] [Abstract][Full Text] [Related]
4. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
5. Recent advancements in epilepsy.
Wyler AR; Vossler DG
Surg Neurol; 1997 Aug; 48(2):106-9. PubMed ID: 9242233
[TBL] [Abstract][Full Text] [Related]
6. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
7. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
[TBL] [Abstract][Full Text] [Related]
8. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Hutton JL; Chadwick DW
Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
Johannessen SI
Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
[TBL] [Abstract][Full Text] [Related]
10. An audit of the new antiepileptic drugs in clinical neurological practice.
McDonnell GV; Morrow JI
Seizure; 1996 Jun; 5(2):127-30. PubMed ID: 8795128
[TBL] [Abstract][Full Text] [Related]
11. New antiepileptic drugs.
Bourgeois BF
Curr Opin Pediatr; 1996 Dec; 8(6):543-8. PubMed ID: 9018437
[TBL] [Abstract][Full Text] [Related]
12. New antiepileptic drugs.
Bourgeois BF
Arch Neurol; 1998 Sep; 55(9):1181-3. PubMed ID: 9740111
[TBL] [Abstract][Full Text] [Related]
13. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
Lhatoo SD; Wong IC; Polizzi G; Sander JW
Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
[TBL] [Abstract][Full Text] [Related]
14. New antiepileptic drugs--an explosion of activity.
Leach JP; Brodie MJ
Seizure; 1995 Mar; 4(1):5-17. PubMed ID: 7788108
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of new antiepileptic drugs.
Gram L
Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for refractory localization-related seizures.
Brodie MJ
Epilepsia; 2001; 42 Suppl 3():27-30. PubMed ID: 11520319
[TBL] [Abstract][Full Text] [Related]
17. The role of newer anticonvulsants in the management of epilepsy.
Kilpatrick C
Aust N Z J Med; 1995 Apr; 25(2):114-6. PubMed ID: 7605291
[No Abstract] [Full Text] [Related]
18. New antiepileptic drugs.
Harden CL
Neurology; 1994 May; 44(5):787-95. PubMed ID: 8190276
[No Abstract] [Full Text] [Related]
19. Overview of the safety of newer antiepileptic drugs.
Shorvon S; Stefan H
Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiepileptic drugs on cognition.
Aldenkamp AP
Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
